Document is current

Any future updates will be listed below

Enhanced external counterpulsation (EECP) decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment

Crossref DOI link: https://doi.org/10.1007/s00592-016-0869-6

Published Online: 2016-06-09

Published Print: 2016-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark